PerkinElmer, Inc. offers automated analytical solutions designed to optimize the efficiency of your daily workflows. With our innovative gene therapy solutions enabling accurate, quantitative, high-throughput characterization of adeno-associated virus (AAV) particles, monoclonal antibodies, and proteins, PerkinElmer is committed to innovating for a healthier world. As demand for developing new vaccines and therapeutic agents rapidly increases, it is even more important for scientists and companies to find ways to do more with their limited time. Learn how PerkinElmer’s innovative solutions help to close this gap and deliver high-quality results in record speed.